Identification of epidermal growth factor receptor as a target of Cdc25A protein phosphatase

Ziqiu Wang1, Meifang Wang, John S Lazo

  • 1Thomas E. Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA.

Insights

Cdc25A phosphatase interacts with epidermal growth factor receptor (EGFR), influencing cell cycle and mitogenic signaling. Inhibiting Cdc25A prolongs EGFR tyrosine phosphorylation, linking cell cycle control to EGFR signaling.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Cdc25A is a dual-specificity protein phosphatase crucial for cell cycle progression.
  • While known to dephosphorylate cyclin-dependent kinases, Cdc25A's broader substrate interactions are under investigation.
  • Epidermal growth factor receptor (EGFR) signaling is vital for cell growth and proliferation.

Purpose of the Study:

  • To investigate the physical and functional interaction between Cdc25A and EGFR.
  • To determine the role of Cdc25A in regulating EGFR tyrosine phosphorylation.
  • To elucidate the functional consequences of the Cdc25A-EGFR interaction on mitogenic signaling.

Main Methods:

  • Co-immunoprecipitation assays to demonstrate physical interaction between Cdc25A and EGFR.
  • In vitro phosphatase assays using purified GST-Cdc25A and cell lysates.
  • Treatment with Cdc25A inhibitor Cpd 5 to assess its effect on EGFR phosphorylation.
  • Functional studies in NR-6 fibroblasts expressing wild-type and mutant EGFR.

Main Results:

  • Cdc25A physically and functionally interacts with EGFR in Hep3B human hepatoma cells.
  • Cdc25A inhibitor Cpd 5 prolonged EGFR tyrosine phosphorylation by inhibiting Cdc25A activity within the Cdc25A-EGFR complex.
  • Both purified and endogenous Cdc25A dephosphorylated tyrosine-phosphorylated EGFR.
  • The interaction was dependent on the EGFR C terminus and kinase domain.

Conclusions:

  • Cdc25A directly dephosphorylates tyrosine-phosphorylated EGFR.
  • This dephosphorylation activity links Cdc25A's cell cycle regulatory function to EGFR-mediated mitogenic signaling.
  • The findings reveal a novel role for Cdc25A in regulating growth factor receptor signaling pathways.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: